Home >
Medicine Info >
Newbona 70 mg Jelly
Loading interface...

Newbona 70 mg Jelly

Manufactured byAkumentis Healthcare Ltd.
ContainsAlendronate
Description
Newbona 70 mg Jelly is used for the treatment of osteoporosis (a condition in which the bones become thin and weak and break easily) in postmenopausal women.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Newbona 70 mg Jelly

  • Abdominal pain
  • Nausea and vomiting
  • Heartburn
  • Difficulty with swallowing
  • Irregular heartbeat
  • Loss of appetite
  • Loosening of the teeth
  • Joint or muscle pain
  • Swelling of ankles or feet
  • Flu like symptoms

Uses of Newbona 70 mg Jelly

What is it prescribed for?

  • Osteoporosis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 3 weeks of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 12-30 weeks.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to alendronate or any other components present along with the formulation.

Hypocalcemia

This medicine may cause a decrease in the blood calcium levels, hence it is not recommended for use in patients with low calcium levels.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Severe bone, joint and/or muscle pain

This medicine may cause severe bone, joint, and/or muscle pain. Report any such symptoms to the doctor on priority. Your doctor may advise you to discontinue therapy based on your clinical condition.

Thigh and hip bone fracture

The use of this medicine may increase the risk of a thigh and hip bone fracture. Care should be taken to avoid any falls or other trauma to reduce this risk.

Use in children

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Osteonecrosis of the jaw

This medicine may rarely cause osteonecrosis of the jaw in some patients. This risk is especially higher in patients undergoing invasive dental procedures. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Driving or operating machinery

This medicine may cause dizziness, blurred vision, weakness, etc. in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience any of these symptoms.

Missed Dose

If the dose is missed, take the dose the next morning and continue with the regular dosing schedule of one jelly once a week.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Gentamicin

Nonsteroidal anti-inflammatory medicines

Deferasirox

Etelcalcetide

Disease interactions

Kidney disease

This medicine should be used with extreme caution in patients with kidney impairment due to the increased risk of severe adverse effects. Close monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition. It is not recommended for use in patients with severe kidney impairment.

Hypocalcemia

This medicine is not recommended for treating osteoporosis in patients with decreased calcium levels (hypocalcemia). Calcium and vitamin D levels should be checked before starting therapy with this medicine. It is also important to continue the appropriate supplementation of calcium and vitamin D during treatment with this medicine.

Asthma

This medicine should be used with caution in patients with asthma due to the increased risk of worsening of the patient's condition. Close monitoring of such patients for any adverse effects is necessary during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
The desired effect will not be achieved if it is taken along with food. It is advised to take this medicine first thing in the morning and at least 30 minutes before eating or drinking something.
The combined use of this medicine and products containing calcium, magnesium, aluminum, or iron may reduce the effectiveness of Newbona 70 mg Jelly. It is recommended to take such products for at least 30 minutes after taking Newbona 70 mg Jelly. It is advised that you inform the doctor about all your medicines including herbs and supplements before using this medicine to avoid such interactions.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Follow all the instructions given by your doctor and administer this medicine exactly as advised. Do not take in larger or smaller amounts than prescribed. Seek emergency medical treatment in case of any severe side effects.
Miscelleneous

To be taken on an empty stomach

To be taken in morning

Does not cause sleepiness

How it works
This medicine increases bone thickness and reduces the chances of bone breakage.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Bisphosphonates

Schedule

Schedule H

Alendronate: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 3 June 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a601011.html

Alendronic acid - DrugBank [Internet]. Drugbank.ca. 2020 [cited 4 June 2020]. Available from:

https://www.drugbank.ca/drugs/DB00630

Alendronate sodium [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 4 June 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Alendronate-sodium

Search results detail| Kusurino-Shiori(Drug information Sheet) [Internet]. Rad-ar.or.jp. 2020 [cited 22 June 2020]. Available from:

http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=34612
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 22 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.